# Intralesional Injection of STS in Treatment of Calcinosis

> **NCT06672822** · PHASE2 · RECRUITING · sponsor: **Robyn T. Domsic, MD, MPH** · enrollment: 20 (estimated)

## Conditions studied

- Systemic Sclerosis (SSc)
- Dermatomyositis
- Mixed Connective Tissue Disease (MCTD)
- Calcinosis

## Interventions

- **DRUG:** Sodium Thiosulfate (STS)

## Key facts

- **NCT ID:** NCT06672822
- **Lead sponsor:** Robyn T. Domsic, MD, MPH
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-17
- **Primary completion:** 2028-08-31
- **Final completion:** 2029-05-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-05-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06672822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06672822, "Intralesional Injection of STS in Treatment of Calcinosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06672822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*